JP2024534420A5 - - Google Patents
Info
- Publication number
- JP2024534420A5 JP2024534420A5 JP2024516798A JP2024516798A JP2024534420A5 JP 2024534420 A5 JP2024534420 A5 JP 2024534420A5 JP 2024516798 A JP2024516798 A JP 2024516798A JP 2024516798 A JP2024516798 A JP 2024516798A JP 2024534420 A5 JP2024534420 A5 JP 2024534420A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- pharmaceutically acceptable
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245718P | 2021-09-17 | 2021-09-17 | |
| US63/245,718 | 2021-09-17 | ||
| PCT/US2022/043660 WO2023043923A1 (en) | 2021-09-17 | 2022-09-15 | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534420A JP2024534420A (ja) | 2024-09-20 |
| JP2024534420A5 true JP2024534420A5 (https=) | 2025-08-07 |
Family
ID=85603496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516798A Pending JP2024534420A (ja) | 2021-09-17 | 2022-09-15 | 環状スルホンアミドリボヌクレオチドレダクターゼ（ｒｎｒ）阻害剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250002486A1 (https=) |
| EP (1) | EP4401728A4 (https=) |
| JP (1) | JP2024534420A (https=) |
| KR (1) | KR20240101555A (https=) |
| CN (1) | CN118434417A (https=) |
| AU (1) | AU2022345092A1 (https=) |
| CA (1) | CA3231660A1 (https=) |
| IL (1) | IL311458A (https=) |
| MX (1) | MX2024003258A (https=) |
| TW (1) | TW202328121A (https=) |
| WO (1) | WO2023043923A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3187760A1 (en) | 2020-08-12 | 2022-02-17 | Boundless Bio, Inc. | Replication stress pathway agent compositions and methods for treating cancer |
| US20260085067A1 (en) * | 2022-09-13 | 2026-03-26 | Boundless Bio, Inc. | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
| WO2025049814A2 (en) * | 2023-09-01 | 2025-03-06 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE067028T2 (hu) * | 2016-05-31 | 2024-09-28 | Taiho Pharmaceutical Co Ltd | Ribonukleotid reduktáz inhibitor szulfonamid vegyületek vagy sóik rák kezelésére |
| ES2969901T3 (es) * | 2017-11-29 | 2024-05-23 | Taiho Pharmaceutical Co Ltd | Cocristal de ácido benzoico y compuesto de sulfonamida para el tratamiento de tumores |
| MA51228A (fr) * | 2017-11-29 | 2020-10-07 | Taiho Pharmaceutical Co Ltd | Agent antitumoral |
| US20220226291A1 (en) * | 2019-05-29 | 2022-07-21 | Taiho Pharmaceutical Co., Ltd. | Combination Treatment of Cancer Using Sulfonamide Compound and Immune Regulator |
| WO2022187200A1 (en) * | 2021-03-02 | 2022-09-09 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) inhibitors and uses thereof |
-
2022
- 2022-09-15 JP JP2024516798A patent/JP2024534420A/ja active Pending
- 2022-09-15 CA CA3231660A patent/CA3231660A1/en active Pending
- 2022-09-15 TW TW111134951A patent/TW202328121A/zh unknown
- 2022-09-15 EP EP22870692.5A patent/EP4401728A4/en active Pending
- 2022-09-15 AU AU2022345092A patent/AU2022345092A1/en active Pending
- 2022-09-15 CN CN202280075394.XA patent/CN118434417A/zh active Pending
- 2022-09-15 KR KR1020247012612A patent/KR20240101555A/ko active Pending
- 2022-09-15 MX MX2024003258A patent/MX2024003258A/es unknown
- 2022-09-15 IL IL311458A patent/IL311458A/en unknown
- 2022-09-15 WO PCT/US2022/043660 patent/WO2023043923A1/en not_active Ceased
- 2022-09-15 US US18/692,503 patent/US20250002486A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520481A5 (https=) | ||
| JP2024534420A5 (https=) | ||
| JP2024514223A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2022505987A5 (https=) | ||
| JP2024529070A5 (https=) | ||
| JP2024539946A5 (https=) | ||
| JP2022516469A5 (https=) | ||
| JP2019529490A5 (https=) | ||
| IL283592B2 (en) | Inhibitors of apol1 and methods of using same | |
| JP2023535453A5 (https=) | ||
| JP2023515618A5 (https=) | ||
| RU2019100164A (ru) | Гетероциклическое соединение, используемое как ингибитор fgfr | |
| JP2023553835A5 (https=) | ||
| JP2024541910A5 (https=) | ||
| JP2015531773A5 (https=) | ||
| JP2025502943A5 (https=) | ||
| JP2023520924A5 (https=) | ||
| JP2009524691A5 (https=) | ||
| RU2007124329A (ru) | ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ | |
| JP2022522694A5 (https=) | ||
| JP2017504595A5 (https=) | ||
| RU2017136715A (ru) | Производное имидазоизоиндола, способ его получения и медицинское применение | |
| JP2023537271A5 (https=) | ||
| JP2022511477A5 (https=) |